Questions about sunscreen persist · sunscreen that may cause acne. • The FDA recommends more...

A Publication of the American Academy of Dermatology Association

SATURDAY • MARCH 4, 2017

Using value to reduce health costs

Acne guidelines clarify role of antibiotics

Exhibit hall floor plan and exhibitor listing4 10 Follow @AADmember on

Twitter! #AAD176

Four Late-breaking Research sessions presented today

The latest research in dermatology will be spotlighted in 48 abstracts that will be presented in

four two-hour sessions Saturday. The abstracts address the latest observations in clinical, surgical, and pediatric dermatology, as well as dermatopathology, therapeutics, and basic research.

Researchers were invited to submit abstracts describing their most recent results. The 48 abstracts were chosen from about 180 submitted. Those being presented received the top scores, and the authors will discuss their

findings in oral presentations during the sessions.

“Biologics and psoriasis continue to be very important,” Hensin Tsao, MD, PhD, director of the sessions, said of the abstracts submitted. “We are seeing atopic

dermatitis coming into the picture in the past couple of years, and this year in particular we are seeing a lot of interesting pediatric studies come out,” he said.

The schedule of Late-breaking Research sessions:• Clinical Trials (F056), 9-11 a.m.

in Room W415D• Clinical Studies/Pediatric (F072),

1-3 p.m. in Room W308A• Procedural Dermatology (F073),

1-3 p.m. in Room 304C• Basic Science/Cutaneous Oncology/

Pathology (F085), 3:30-5:30 p.m. in Room 304A“There has been such enthusiasm

to put research into the forefront at the Annual Meeting with these Late-breaking Abstract sessions,” Dr. Tsao said. “More than ever, people realize that great science has been, and will continue to be, a vital part of our specialty. I am glad to see that the Late-breaking Abstract sessions are teeming with submissions. Dermatologic research is definitely generating a buzz at this meeting.”

See SUNSCREEN page 25

Questions about sunscreen persistMedia reports on effectiveness of sunscreens can confuse consumers

C onsumers often have questions about what kind of sunscreen to use and how to use it because of confusing reports.

Dermatologists need to be ready to confidently answer those questions. In the end, the best answer is that data show that using higher SPF sunscreens helps reduce the risk of skin cancer.

“Dermatologists have to understand reports about sunscreens in the media and understand their weaknesses so that when we talk to patients we can be objective,” Darrell Rigel, MD, MS, said in an interview about his Friday presentation, “Does High SPF Sunscreen Offer Better Protection?”

Consumer confusion arises from two annual reports published each May by Consumer Reports and the Environmental Working Group (EWG), said Dr. Rigel, clinical professor at the Ronald O. Perelman department of dermatology at the New York University School of Medicine. He spoke during “Photoprotection” (F043).

“Last year, Consumer Reports said that many sunscreens did not meet their SPF levels in its testing, which is different from the way the government does its testing. That is part of the issue, but the concern was that sunscreens were not meeting their rated SPF,” Dr. Rigel said.

In its report, the EWG lowered its scores of sunscreens if they had ingredients EWG determined to be detrimental or if they

were applied as a spray or a powder.“In that report, nobody had integrated

the data to make it be clinically relevant. Some of these reports are taken out of context in terms of risk,” he said. “The other thing is that the sunscreen products they do recommend, if you click on them, they go right to Amazon and they get click-through revenues for them.

“It is not an objective system, but consumers see it. It is important that we, as dermatologists, know this and explain that the rating system is done by looking at ingredients that may not be dangerous whatsoever. It is not really measuring how effective they are in terms of protecting you from sunburn,” Dr. Rigel said.

Another concern of consumers is the effectiveness of sunscreens in reducing the risk of cancer. That is a question answered by many prospective studies, including a recent study that showed regularly using sunscreens rated SPF 15 or greater reduced the risk of getting melanoma by one-third, he said.

Even though it is accepted that the greater the SPF the better, there has been a debate on whether to cap the SPF level at 50. SPF 50 blocks 98 percent of the sun’s rays while SPF 100 blocks 99 percent of the rays, but at a greater cost. In addition, the greater concentration of chemicals required for a greater SPF could lead to more allergic reactions.

An important factor in this analysis

is that most consumers do not apply sunscreen at the tested and recommended amounts, so it is not as effective as it could be, but under-applying a higher SPF sunscreen will still provide UV protection at a reasonable level. Dr. Rigel said he recently completed a prospective trial, which has not been published, that backs up this reasoning.

“It was a real-world usage study. This study definitively showed an advantage of SPF 100 over 50. The higher SPF sunscreens do make a difference and protect more effectively,” he said.

Dr. Rigel discussed other points about suncreens:

Hensin Tsao, MD, PhD

Darrell Rigel, MD, MS, discusses sunscreens during “Photoprotection.”

AmLactin® Alpha-Hydroxy Therapy contains more than 3X* the concentration of lactic acid, a powerful AHA, compared to other top-selling therapeutic moisturizers. Our powerful formulas deeply moisturize and boost the skin’s natural renewal process through gentle exfoliation.

Visit amlactin.com to learn more!

Relief for persistent dry skin!

3X*AHA

*Data on file. EW Competitor Comparison Study Results. June 2016.

Sunburn Alert: This product contains an alpha-hydroxy acid (AHA) that may increase your skin’s sensitivity to sunburn.Be sun smart: Use sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterward.

100 College Road West, Princeton, NJ 08540AmLactin and ULTRAPLEX are registered trademarks of Upsher-Smith Laboratories, Inc.©2017 Fougera Pharmaceuticals Inc. All rights reserved.S-RSZ-1340164 01/2017

Brought to you by

Visit us at booth 1627

T:10.875”T:15”

B:11.125”B:15.25”

DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 2017 3

Board of Directors

President-Elect Vice President-Elect Nominating Committee Member Representatives

Meet your 2017 slate of candidates

The American Academy of Dermatology has selected its candidates in this year’s election. The Nominating

Committee voted to present the following slate of candidates (listed in random order) to the membership for the 2017 Academy election of officers, directors, and Nominating Committee member representatives. Kenneth J.

Tomecki, MDGeorge J. Hruza, MD

Jane M. Grant-Kels, MD

Alice Gottlieb, MD, PhD

Stephen Mandy, MD

Dirk Elston, MD

Seemal R. Desai, MD

Adelaide A. Hebert, MD

Scott M. Dinehart, MD

Christen M. Mowad, MD

Diane S. Berson, MD

Seth L. Matarasso, MD

Abby S. Van Voorhees, MD

Bruce A. Brod, MD

Vol. 29, No 2 March 4, 2017

PresidentAbel Torres, MD, JD

Physician ReviewerMarta Van Beek, MD, MPH

Executive Director & CEOElaine Weiss, JD

Director, Creative and PublishingLara Graf

Associate Director, PublishingKatie Domanowski

Senior Manager, Dermatology WorldRichard Nelson, MS

Managing Editor, Special PublicationsDean Monti, MFA

Staff WriterDanielle Piquette

Lead DesignerNicole Torling

Senior Graphic DesignerTheresa Oloier

Printed in U.S.A. ©2017American Academy of

Dermatology Association930 E. Woodfield Road

Schaumburg, IL 60173-4729Phone (847) 330-0230; Fax (847) 330-0050

www.aad.org

Produced for the American Academy of Dermatology

by Ascend Integrated Media

Rhonda WickhamVice President of Content

Greg SackuvichEditor in Chief

Tim NordDesigner

www.ascendmedia.com

A Publication of the American Academy of Dermatology The future of dermatologyPlenary lectures to highlight advances in research, practice

A highlight of every AAD Annual Meeting is the Plenary, with its wealth of lectures addressing topics of interest

about dermatology around the world. The Plenary features four scientific and clinical lectures, an invited speaker, and addresses by Academy leaders.

Named lectures will address telemedicine, propranolol, cancer development, and psoriasis, and the Guest Speaker will discuss the threat of Ebola. The Plenary will also feature addresses by AAD President Abel Torres, MD, JD, MBA, and President-elect Henry Lim, MD, from 8 to 11:30 a.m. Sunday in the Chapin Theater.

Clarence S. Livingood, MD, Award and LectureshipBetter patient access is a key component of improved health care, and telemedicine is expected to play a key role, especially in dermatology. Telemedicine can be used to improve triage, urgent care, inpatient consultation, direct follow-up with patients, and patient monitoring.

Carrie L. Kovarik, MD, will examine the potential of these changes in technology when she presents “Telemedicine and the Future of Medicine.” She is an assistant professor of dermatology, dermatopathology, and infectious diseases at the University of Pennsylvania.

In her lecture, Dr. Kovarik will discuss recommendations for standard practices in telemedicine to ensure quality and the role of the specialty in telemedicine.

Eugene J. Van Scott Award for Innovative Therapy of the Skin and Phillip Frost Leadership LectureThe chance discovery of the positive effects of propranolol on complicated infantile hemangiomas was seen when a newborn was being treated for corticosteroid-induced myocardiopathy. Since 2014, the molecule has increasingly been used as a successful treatment for hemangiomas.

Christine Léauté-Labrèze, MD, will trace that evolution in “Propranolol in Infantile Hemangiomas: A Successful Drug Repurposing.” She is a pediatric dermatologist at Universitaire de Bordeaux in Bordeaux, France.

Lila and Murray Gruber Memorial Cancer Research Award and LectureshipThe treatment of melanomas has improved with an increased knowledge of how moles can evolve from precursor lesions to melanomas. The molecular makeup of melanocytic neoplasms is a key in that evolution.

In his lecture, “How Moles Become Cancer,” Boris C. Bastian, MD, PhD, will discuss his study of lesions

and melanoma. He is a professor of dermatology and pathology at the University of California, San Francisco.

Marion B. Sulzberger, MD, Memorial Award and LectureshipPsoriasis has been the focus of an increased number of studies, which have found that the condition is associated with major cardiovascular events, metabolism disorders, diabetes, end-stage renal disease, and mortality.

Learn more about this research when Joel M. Gelfand, MD, MSCE, presents “Getting to the Heart (and Other Comobidities) of Psoriasis.” He is a professor of dermatology and epidemiology and director of the Psoriasis and Phototherapy Treatment Center at the University of Pennsylvania.

Dr. Gelfand will discuss emerging observational and experimental studies in humans that are better defining the impact of systemic treatment of psoriasis on major health outcomes, such as cardiovascular events.

Guest SpeakerRear Admiral Jordan W. Tappero, MD, MPH, will present “The West African Ebola Epidemic and the Global Health Security Agenda.” He is a senior advisor for Global Health, Center for Global Health (CGH) at the Centers for Disease Control and Prevention.

DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 20174

“I was in the New and Emerging Technologies session this morning, where there were many new things about melanoma and skin cancer. The problem with them is that there are very serious side effects, so we have to think hard about when to use them to treat the patients. There was also good information about sunscreens in the session.”

Cleire Pereira, MDBrasilia, Brazil

“The development of a new biologic for atopic dermatitis — dupilumab,

which works on IL-4. It has not been approved yet, but atopic dermatitis is something I see a lot, and we have only a limited

ability to control the condition.”

Paul Dunn, MDSpokane Valley, Washington

“I think it is about how dupilumab is going to pan out for atopic dermatitis. That is going to be exciting because there has been nothing new for atopic dermatitis in so long.”

Stephanie Weston, MBBSLondon, United Kingdom

“A better understanding of the pathways involved with eczema and atopic dermatitis, and the

development of new drugs that target these specifically, as opposed to the drugs we used to have. We are almost obligated to go back a bit to basic science to understand how these new medications work, but that gives us a much better understanding of the disease.”

Fernanda Bellodi-Schmidt, MDCincinnati, Ohio

Question of the day

What is the most exciting clinical development you’ve heard about recently?

Using value to reduce health costsMedical literature offers guidance in cost-effective treatments

I n a nation divided over the path of health care, there is one fact on which everyone agrees — it all costs too much. Trying to reduce

costs seems a Sisyphean task, so a better approach is to get better value.

A Friday session, “Value in Healthcare: Improving Outcomes and Decreasing Waste” (F033), explained how to read dermatology literature to learn more about the comparative effectiveness of treatments. Three speakers tackled questions such as, “Is it worth spending hundreds of dollars a month on a treatment that produces only modestly improved outcomes?” or “Does a patient on this medication need this much monitoring?”

“Cost-effectiveness is not about the money but it is about what you are getting for the money. It is not about the dollar amount and spending less, it is about spending smarter,” said session speaker Adewole (Ade) Adamson, MD, MPP. “We need to understand in what therapeutic and diagnostic situations you can be more cost-effective.”

Value can seem an abstract concept, but session director Joslyn S. Kirby, MD, an associate professor of dermatology at Penn State University, made it more concrete. She said value can be seen as an equation in which the outcome is divided by the cost.

“We need to understand both parts: the numerator and denominator,” she

said. “We need to know how to measure or assess outcomes, how to understand what a cost is, and where there is an opportunity to recoup some of the waste. We also need to be able to look at the literature, interpret it confidently, and make changes in our practice.”

As an example, recently published literature calls for reduced monitoring of patients using isotretinoin and spironolactone.

“In the last couple of years, there have been papers coming out showing that the side effects of isotretinoin are probably not as common as we think they are,” Dr. Kirby said. “Side effects to the medication that we monitor for with labs are most often seen at the beginning of treatment, and there are very few changes found later in the course of treatment. So there are opportunities to tailor our monitoring practices to what is seen in the data in the literature.”

Speaker Arash Mostaghimi, MD, MPA, MPH, an assistant professor of dermatology at Harvard Medical School, applied the same approach to spironolactone.

“The routine testing for hyperkalemia among young, healthy women taking spironolactone for acne is an unnecessary practice,” Dr. Mostaghimi said. “Eliminating testing reduces costs and removes barriers to using this cheap and effective drug.”

“We are going with where the data

is leading us, and it is leading us toward the idea that additional testing doesn’t necessarily mean additional safety for the patient. Every time we treat a patient, we need to think about why this test, why this drug, why this patient, and why right now? We need to challenge all of our assumptions.”

Dr. Adamson applied the same approach to the use of combination products for acne. Trials show the effectiveness of these products, but at a great cost over other approaches.

“What a lot of people do not look at in a study are the vehicle arm or the group that is not treated with the combination product or the single product,” said Dr. Adamson, an assistant professor of dermatology at the University of North Carolina School of Medicine. “What you don’t notice is that while there is a difference between combination products and vehicle — benzoyl peroxide in particular — that difference is really small.

“If you look at the price comparing benzoyl peroxide to combination products or monotherapy, there is really only a small difference in how much better people get. You may pay $200, $300, or $500 more to get a 5-10 percent benefit. In practice, that may only be a difference of 4 or 5 pimples at a cost of $500. Is that worth it?” Physicians should use GoodRx to check the prices of medications and look for ways to stay current on their reading, Dr. Adamson said.

“In dermatology, there is no easy resource to be able to determine that. I hope with this discussion that we can create a hub or database where this can be found more quickly.”

Adewole (Ade) Adamson, MD, MPP, talks about increasing the value of health care as his fellow speakers, Joslyn S. Kirby, MD, and Arash Mostaghimi, MD, MPA, MPH, listen.

PREPARED BY FCB

Job #: 10687590Releasing as: Native file Production: S. Curry x3029

Colors: 4C AD: C. Anderson

Client: Pfizer AE:

Product: Eucrisa Bleed: 11.125”w x 15.25”h Producer: L. Burgess

Client Code: Trim: 10.875"w x 15"h QC: L.Powell

Date: January 19, 2017 5:44 PM Safety: 10.375"w x 14.5"w Digital Artist: tp,BD, tp, BB, tp,BD

Proof: M6FRAdd’l Info:

Fonts: Co Text M1 Spellcheck: M. Benedetto

FR Spellcheck: Luigi Mennella

Path: PrePress:Pfizer:Eucrisa:10687590:_PACKAGED:10687590_AAD_Annual_Mtg_News:10687590_AAD_Annual_Mtg_News_M6FR

4C Eucrisa AAD Annual Meeting News Ad

AAD food court

Entrance to convention hall

at booth #2589

Now Approved!Connect•the•dots to learn more

PP-CRI-USA-0201 © 2017 Pfizer Inc. All rights reserved. Printed in USA/January 2017

S:10.375”S:14.5”

T:10.875”T:15”

B:11.125”B:15.25”

10687590_AAD_Annual_Mtg_News_M6FR.indd 1 1/19/17 5:52 PM


Vote online at aad.org/aadelection or from the 2017 AAD Annual Meeting Mobile App

Exercise your member right to vote. The leaders of today will influence how

you practice medicine tomorrow.

TELEMEDICINE

SCOPE-OF-PRACTICE

NETWORK ADEQUACY AND TRANSPARENCY

PHYSICIAN PAYMENT REFORM

ACCESS TO DERMATOPATHOLOGY SERVICES

PATIENT ACCESS TO DRUGS/TREATMENTS

NEW VOTING TIMELINE

OPENSMarch 4

CLOSESMarch 18

What’s weighing on YOUR mind?

NEW Election Voting Timeline March 4 – 18

Acne guidelines clarify role of antibiotics with topical therapy

T he highlights of AAD Guidelines of Care for the Management of Acne Vulgaris, including the use of antibiotics,

isotretinoin, hormonal therapy, and physical modalities, as well as the role of diet in acne, will be reviewed during an education session Saturday morning.

“The audience and others in practice

ask: Will this restrict what they are able to do? That is not the intent of guidelines. The intent of the guidelines is to review the literature to see what data are available based on current evidence and then provide recommendations in line with that evidence that would be directly applicable to various clinical scenarios,” said the session director, Bethanee J. Schlosser,

MD, PhD. She was also a member of the workgroup that wrote the guidelines, published last year (J Am Acad Dermatol 2016; 74(5):945-973).

One of the clinical guideline’s strongest statements is on antibiotic therapy, which should not

be used alone, whether it is a topical or systemic antibiotic, said Dr. Schlosser, an associate professor in the department of dermatology at Northwestern University Feinberg School of Medicine.

“If patients do need antibiotics,” she said, “they should always be used in

conjunction with a topical therapy, such as benzoyl peroxide, to decrease antibiotic resistance. A retinoid should also be used to enable patients to more quickly decrease or get off antibiotic therapy.

“The guidelines suggest that after initiating an oral antibiotic, patients should be evaluated at three months.”

The guidelines clarify the use of isotretinoin and its dosing strategies, which will be reviewed in the session. They also address concerns about potential links between isotretinoin and inflammatory bowel disease, depression, and mood disorders while advocating for the monitoring of individual patients for depression and mood disorders, Dr. Schlosser said.

Data regarding hormonal therapy for acne is plentiful, with no one oral contraceptive pill standing apart from others. The discussion of hormonal therapy will also address appropriate patient selection and the use of spironolactone as an off-label treatment for acne.

The role of diet in acne still is not clear, with no obvious dietary triggers in most patients, Dr. Schlosser said. However, the presentation will look at data that reviews a high glycemic index and skim milk in dairy products as possible triggers for acne.

The final presentation will explore physical modalities, such as chemical peels, lasers, and light therapy, but the guidelines note too much variability in procedures and outcomes to advocate their use, she said.

“The guidelines do recommend that you can consider those physical modalities of treatment as adjuvant in patients with acne or those who are not eligible for other therapies, but they should not replace standard-of-care therapy,” Dr. Schlosser said.

Most importantly, the new guideline recommendations differ from the previous guidelines by advocating for a greater emphasis on using topical retinoids both during and following oral antibiotics as maintenance therapy, she said.

“The guidelines are most helpful in terms of identifying what gaps there are in terms of the evidence in existence. They are not supposed to handcuff anyone, but are supposed to provide guidance,” Dr. Scholsser said.

To learn more about the acne guidelines, visit www.aad.org/dw/monthly/2015/august/overusing-acne-antibiotics.

Translating Evidence Into Practice: Acne Guidelines (F048)

9-11 a.m. Saturday

Room W304A

W I N N I N G

P E P T I D E S

A W A R D -

peptide-rich serum for expression lines

Contains multiple layers of new technologyfor reducing the appearance of expression linesaround the eyes, forehead and mouth.

• Formulated with clinical levels of 7 peptides, including two award-winning peptides

• Targets the appearance of 7 types of expression lines

• Keeps skin looking relaxed without losing the ability to express yourself

I N T R O D U C I N G

Visit us at booth #1241. 800.385.6652 revisionskincare.com.

New breakthrough

formula is changing the face

of expression lines.

*Data on file. Results may vary.

Before After 8 weeks*


Breaking News

Preventing burnoutSpeakers to discuss causes, strategies

S peakers will address the factors contributing to frustration and anxiety for today’s dermatologists.

Panelists in the Monday session will explore the silent epidemic of physician burnout and discuss strategies to prevent, identify, and mitigate it for dermatologists.

“This is a groundbreaking discussion for our profession,” said J. Matthew Knight, MD, session director. “Although

dermatologists historically do better than our peers when it comes to job satisfaction, unprecedented bureaucracy coupled with feelings of worthlessness and fatigue are leading to troubling levels of professional burnout in our ranks. This is a unique and important session for any practicing dermatologist.”

Bureaucracy, Compliance, and Burnout: What it Means to Dermatologists (U084)

7:30-8:30 a.m. Monday

Room W315A

Download the new AAD Meeting Mobile App

I t’s back … and better than ever! The AAD Meeting

Mobile App has been redesigned for optimum functionality and easier navigation at the 2017 AAD Annual Meeting. Please note that the old AAD Meetings Mobile App (with the blue AAD logo) is now officially inactive, so you must download the new app with the white AAD logo in the iPhone App store or Google Play.

Overall, the new app will offer the same features as the previous app, which includes the following:• Session Schedule: Listing of sessions

by day, type, category, and speaker; bookmark sessions you like, take notes, or access select session handouts

• Exhibitors: Search by name or category, or view the exhibit hall floor plan

• Speakers: Search by name to see what session they are speaking in

• Maps: Explore floor plans for session rooms

• Ask Me: Discover answers to frequently asked questions• Event listing: Council, Committee, Task Force meetings, Affiliate and Reunion Groups, Industry Expert Sessions, and Industry Non-CME (INC) Programs (previously known as PIPs)• E-Posters: Access e-Posters; search by author, title, category, keyword, or poster number• Audience Response: Access Audience Response Sessions and participate via your mobile device

For instructions, visit www.aad.org/mobile for links on how to

download the app for iPhone and Android smartphones. You may also search “AAD Meetings” in the iPhone App store or Google Play and download the app with the white AAD logo icon.

If you have questions or concerns while at the meeting, visit one of the two Mobile App assistance desks at the Orange County Convention Center in West Lobby B, Level 1, or at The Connection, Hall B4. Both desks will be open Friday through Monday from 7 a.m. to 5:30 p.m.

FAQs

Schedule Exhibitors

Maps

Speakers

CME/Evaluations

Event ListingSearch

Audience Response

2017 AAD Annual Meeting

Orlando, FL • March 3-7, 2017

ORANGE COUNTY CONVENTION CENTER

The Annual Meeting opensThe 2017 AAD Annual Meeting opened Friday with large crowds filling the hallways and registration area of the Orange County Conven-tion Center. The excitement flowed over into the Exhibit Hall, where attendees thronged to see the prod-ucts and services of more than 400 exhibitors. The Annual Meeting will continue through Tuesday.

WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS.

WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS.

©2017 AbbVie Inc. North Chicago, IL 60064 64V-1891925 January 2017 Printed in U.S.A.

IT ONLY TAKES A MINUTE TO MAKE A DIFFERENCETake a quiz. Take a photo. AbbVie will make a donation to AAD’s Camp Discovery for your participation and commitment to patients.

VISIT ABBVIE BOOTH 2053

64V-1891925_2017_AAD_DailyNews_Pledge.indd 2 1/18/17 3:06 PM


#21st Century Oncology ..................................35303Gen Inc./DermLite ......................................26355CC (5-Continent-Congress) ..........................2079

AAbbVie ...............................................2053, 2441 Accredo ........................................................2178Accurate Manufacturing Inc. .........................3271AccuTEC Blades ............................................1965AccuVein ......................................................1070Aclaris Therapeutics Inc. ...............................3526Actelion Pharmaceuticals US ........................2664Action Bag Co. ..............................................1766Acuderm.......................................................2219AD Surgical ..................................................1692Adako USA ...................................................3187Advalight ......................................................1679Advanced Dermatology & Cosmetic

Surgery .....................................................3215Advanced MD Inc. ........................................2177Advanced Rad Solutions ................................1058Advanced Skin & Hair ...................................1360

Advanced Technology Laser Co. Ltd. ..............3192Aerolase ........................................................1521Aesthetic Guide, The .....................................1335Agnes formerly Gowoonsesang Cosmetics ....1265Allergan ........................................................2253Allied Powers LLC .........................................3389Allina Health ................................................3588Alma Lasers ..................................................2461American Board of Dermatology ...................3134American College of Phlebology ....................3491American Society for

Dermatologic Surgery ...............................2426American Society for Mohs Surgery ...............2723Amgen Inc. ...................................................2553AMP Medical Products LLC ..........................3412Anne Arundel Dermatology, P.A. ...................3391AnteAGE MD by Cellese ...............................1081Anthony Products/Gio Pelle ..........................3305Anutra Medical .............................................3558AP Easy Software Solutions ...........................1038AP Medesthetics Inc./VeinGogh ....................3493Aqua Pharmaceuticals ...................................1339Aquavit Pharmaceuticals Inc. ........................2381Ascentium Capital LLC .................................1036Asclepion Laser Technologies ........................1533Asembia LLC ................................................1062

Aubio Life Sciences .......................................3386Aurora Diagnostics .......................................1041AzaClear .......................................................3566

BBako Integrated Physician Solutions ..............1128Bank of America Practice Solutions ...............1264Bayer ............................................................2041Baylor Scott & White Health ..........................1567Beiersdorf Inc. ..............................................2753Beijing Sincoheren

S&T Development Co. Ltd. ........................3458Beijing Syntech Laser Co. Ltd. .......................3074Bellaire Industry/Mesopen ............................2977Benev Co. Inc. ..............................................3075Bio-Oil ..........................................................2375Biodermis ...........................................2431, 3293 Biofrontera Inc..............................................3579Biogenix Skin Sciences ..................................1186Biologica Technologies ..................................1040Biomed Diagnostics ......................................3388Biopelle Inc. .................................................1919BioPharmX ...................................................3390Bios SRL .......................................................1390bioskin GmbH ..............................................1261

Blaine Labs Inc. ............................................3416Bloq-UV .......................................................1691Boehringer Ingelheim

Pharmaceuticals Inc. .................................3527Bovie Medical ...............................................2371brandMD Skin Care ......................................3453Brazilian Society

for Dermatological Surgery ........................2475Brymill Cryogenic Systems ............................2226BTL ..............................................................1133

CCabana Life ...................................................3543Caliber Imaging & Diagnostics ......................1866Canfield Scientific .........................................1927Capillus LLC .................................................2683CareCredit ....................................................1127CarePath Diagnostics ....................................1768Carismed GmbH ..........................................1071Castle Biosciences Inc. ..................................1110Celgene Corp. ...............................................1053Centura Pharmaceuticals Inc. ........................1064Chemistry Rx ................................................2884Chemotechnique Diagnostics/

Dormer Laboratories .................................1662

Annual Meeting exhibitors Listing as of Feb. 14. For the most up-to-date listing, go to show.aad.org/annual17/ec/forms/attendee/indexTab.aspx

1004 1005

1006

1008

1011

1012 1013

1014 1015

1016 1017

1019

1020 1021

1023

1026 1027

1029

1030 1031

1032

1035

1036

1038

1040 1041

1044

1052 1053

1054

1056

1058

1060

1062

1064 1065

1066

1068

1070 1071

1074 1075

1076

1078

1080 1081

1082 1083

1084 1085

1086 1087

1088

1090 1091

1092

1105

1110

1114 1115

1116

1118

1120 1121

1126 1127

1128

1130

1133

1165

1169

1170

1175

1177

1180 1181

1182 1183

1186 1187

1193

1205

1207

1213

1219

1231

1241

1253

1261

1264 1265

1266

1270

1274 1275

1278

1281

1282

1286 1287

1288 1289

1290 1291

1293

1304 1305

1308

1313

1319

1327

1329

1331

1335

1339

1353

1360 1361

1366 1367

1375

1377

1381

1386

1389

1390

1426 1427

1432 1433

1439

1461

1469

1474 1475

1476

1481

1489

1505

1515

1521

1527

1529

1533

1539

1553

1563

1567

1569

1575

1577

1581

1589

1591

1593

1605

1619

1626 1627

1635

1653 1661

1662

1666 1667

1668

1671

1674 1675

1676

1679

1683

1688 1689

1691

1692 1693

1719

1766 1767

1768 1769

1770 1771

1774 1775

1778

1783

1788

1819

1831

1866 1867

1870

1875

1877

1919

1927

1930

1937

1953

1960 1961

1965

1966

1969

1974 1975

1978

20002005

2019

2027

2035

2041

2053

2060

2064

2069

2074 2075

2078 2079

2127

2135

2174 2175

2177

2178

2219

2226 2227

2231

2253

2271

2274 2275

2276

2319

2326 2327

2370 2371

2375

2379

2381

2383

2389

2405

2417

2426

2431

2435

2441

2453

2461

2470

2474 2475

2478

2482 2483

2489

2505

2523

2527

2530

2535

2536

2541

2553

2565

2567

2575

2581

2583

2589

2622 2623

2635

2664 2665

2675

2680

2683

2684

2722 2723

2727

2735

2741

2753

2767

2775

2781

2785

2787

2791

2805

2822

2827

2834 2835

2867

2875

2880

2883

2884

2886

2889

2922 2923

2953

2963

2969

2971

2975

2977

2981

2989

3005

3015

3022

3031

3035

3041

3062 3063

3068

3074 3075

3081

3089

3127

3130

3134

3153

3161

3163

3169

3175

3187

3188

3191

3192

3205

3211

3215

3219

3221

3239

3260 3261

3264

3267

3269

3271

3286 3287

3291

3293

3305

3310

3313

3314 3315

3318

3320 3321

3327

3333

3343

3353

3359

3363

3365

3366

3368 3369

3375

3381

3386 3387

3388 3389

3390 3391

3404 3405

3406 3407

3408

3410

3412 3413

3414

3416

3419

3423

3427

3435

3445

3453

3458 3459

3460 3461

3462

3464 3465

3469

3471

3475

3481

3486 3487

3488 3489

3491

3492 3493

3504 3505

3508 3509

3513

3515

3518 3519

3520

3523

3526 3527

3528

3530 3531

3533

3537

3541

3543

3544 3545

3553

3557

3558 3559

3563

3564

3566 3567

3570 3571

3575

3579

3581

3583

3585

3586 3587

3588 3589

3590 3591

733

Roo

m

Roo

m 4

05R

oom

409

Roo

m 4

13R

oom

417

Roo

m 4

21R

oom

429

Roo

m 4

33R

oom

437

Roo

m 4

41R

oom

445

Roo

m 4

53R

oom

457

Roo

m 4

61R

oom

465

Roo

m 4

69

Roo

m 5

04

Roo

m 5

05

Roo

m 5

08

Roo

m 5

09

Roo

m 5

12

Roo

m 5

13

Roo

m 5

16

Roo

m 5

17

Roo

m 5

20

Roo

m 5

21

Roo

m 5

28

Roo

m 5

29

Roo

m 5

32

Roo

m 5

33

Roo

m 5

36

Roo

m 5

37

Roo

m 5

40

Roo

m 5

41

Roo

m 5

44

Roo

m 5

45

Roo

m 5

52

Roo

m 5

53

Roo

m 5

56

Roo

m 5

57

Roo

m 5

60

Roo

m 5

61

Roo

m 5

64

Roo

m 5

65

Roo

m 5

68

Roo

m 5

69

Roo

m 6

04R

oom

608

Roo

m 6

12R

oom

616

Roo

m 6

20R

oom

628

Roo

m 6

32R

oom

636

Roo

m 6

40R

oom

644

Roo

m 6

52R

oom

656

Roo

m 6

60R

oom

668

SEATING AREA

PLAN

TER

SEATING AREA

PLAN

TER

SEATING AREA

PLAN

TER

SEATING AREA

PLAN

TER

SEATING AREA

PLAN

TER

FX FX

FX

FX

FHC

FX

FX

FX

FX

FX

FX

FX FX

FX

FXFHC

FX

FX FX FX FX FX FX FX FX

FHC FXFHCFXFHCFHCFHC

FX

FHB

EXIT EXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXIT

EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT

HALL WB4 ENTRANCEHALL WB2 & WB3 ENTRANCE

HALL WA4 ENTRANCE HALL WB1 ENTRANCE

HALL WA3 ENTRANCEHALL WA2 ENTRANCEHALL WA1 ENTRANCE

30'10'10'10'

18'9'3"9'4"

18'

10'76'

10'

27'10'

17'6"7'8"

19'10' 10'

17'6"8'

10'19'

10'FI

RE

DO

OR

DO

NO

T BL

OC

K39' 39'39'2"39'2"

16'-6"10'

10'-8"

10' 10'

5'5"

10'

16'-6"10'

10'-8" 16'-6"10'

10'-8"10'

18'-6" 34' 10'-7"10'

46'-4" 46'-5" 10'-7" 30'-8"11'-4"

WA1 WA2 WA3 WA4 WB1 WB2 WB3 WB4

WF WF WF WF WF WF WF WF WF WF WF

WFWF

WF

UPDN

UPUP

DIRECTIONAL

DIRECTIONAL

DIRECTIONAL

DIRECTIONAL

FIR

E D

OO

RD

O N

OT

BLO

CK

BLO

CK

DO

NO

T

#4 #5 #6 #7Seating Area Seating Area Seating Area Seating Area8'

21'

27'

8'21'

8'21'

8'21'

27'TILED FLOOR AREA TILED FLOOR AREA

TILED FLOOR AREA TILED FLOOR AREA


L2-01A

L2-0

1B

L2-03

L2-04A L2-04B

L2-05

L2-06L2-07

L2-09B L2-09A

L2-10 L2-14

L2-15A L2-15B

L2-12L2-13

L2-17A L2-17B

L2-16A L2-16B L2-16C L2-16D L2-16EL2-18

L2-23

L2-19

L2-20A

L2-20C

L2-20B

L2-24A L2-24B

L2-26A L2-26CL2-26B

L2-21 L2-22 L2-28A L2-28BL2-29 L2-34

L2-25A L2-25B

L2-32L2-33

L2-37A L2-37B

L2-36A L2-36B L2-36C L2-36D L2-36EL2-41

L2-39L2-40

L2-38 L2-42 L2-43

@75.625" @76" @75.75"

NOTMEASURED

(HAD MIS WRAP)

0001

0002

PR

IVA

TE E

XP

O M

EE

TIN

G S

UIT

ES

INDUSTRYEXPERT

SESSIONS

FOOD COURT

AADTHE CONNECTION

(e-Posters andPresentations,AAD Resource

Center,Networking

Center/e-Center)

EXHIBITS

▲

2018SPACE

SELECTIONOFFICE


Continued on page 12

Map

1004 1005

1006

1008

1011

1012 1013

1014 1015

1016 1017

1019

1020 1021

1023

1026 1027

1029

1030 1031

1032

1035

1036

1038

1040 1041

1044

1052 1053

1054

1056

1058

1060

1062

1064 1065

1066

1068

1070 1071

1074 1075

1076

1078

1080 1081

1082 1083

1084 1085

1086 1087

1088

1090 1091

1092

1105

1110

1114 1115

1116

1118

1120 1121

1126 1127

1128

1130

1133

1165

1169

1170

1175

1177

1180 1181

1182 1183

1186 1187

1193

1205

1207

1213

1219

1231

1241

1253

1261

1264 1265

1266

1270

1274 1275

1278

1281

1282

1286 1287

1288 1289

1290 1291

1293

1304 1305

1308

1313

1319

1327

1329

1331

1335

1339

1353

1360 1361

1366 1367

1375

1377

1381

1386

1389

1390

1426 1427

1432 1433

1439

1461

1469

1474 1475

1476

1481

1489

1505

1515

1521

1527

1529

1533

1539

1553

1563

1567

1569

1575

1577

1581

1589

1591

1593

1605

1619

1626 1627

1635

1653 1661

1662

1666 1667

1668

1671

1674 1675

1676

1679

1683

1688 1689

1691

1692 1693

1719

1766 1767

1768 1769

1770 1771

1774 1775

1778

1783

1788

1819

1831

1866 1867

1870

1875

1877

1919

1927

1930

1937

1953

1960 1961

1965

1966

1969

1974 1975

1978

20002005

2019

2027

2035

2041

2053

2060

2064

2069

2074 2075

2078 2079

2127

2135

2174 2175

2177

2178

2219

2226 2227

2231

2253

2271

2274 2275

2276

2319

2326 2327

2370 2371

2375

2379

2381

2383

2389

2405

2417

2426

2431

2435

2441

2453

2461

2470

2474 2475

2478

2482 2483

2489

2505

2523

2527

2530

2535

2536

2541

2553

2565

2567

2575

2581

2583

2589

2622 2623

2635

2664 2665

2675

2680

2683

2684

2722 2723

2727

2735

2741

2753

2767

2775

2781

2785

2787

2791

2805

2822

2827

2834 2835

2867

2875

2880

2883

2884

2886

2889

2922 2923

2953

2963

2969

2971

2975

2977

2981

2989

3005

3015

3022

3031

3035

3041

3062 3063

3068

3074 3075

3081

3089

3127

3130

3134

3153

3161

3163

3169

3175

3187

3188

3191

3192

3205

3211

3215

3219

3221

3239

3260 3261

3264

3267

3269

3271

3286 3287

3291

3293

3305

3310

3313

3314 3315

3318

3320 3321

3327

3333

3343

3353

3359

3363

3365

3366

3368 3369

3375

3381

3386 3387

3388 3389

3390 3391

3404 3405

3406 3407

3408

3410

3412 3413

3414

3416

3419

3423

3427

3435

3445

3453

3458 3459

3460 3461

3462

3464 3465

3469

3471

3475

3481

3486 3487

3488 3489

3491

3492 3493

3504 3505

3508 3509

3513

3515

3518 3519

3520

3523

3526 3527

3528

3530 3531

3533

3537

3541

3543

3544 3545

3553

3557

3558 3559

3563

3564

3566 3567

3570 3571

3575

3579

3581

3583

3585

3586 3587

3588 3589

3590 3591

733

Roo

m

Roo

m 4

05R

oom

409

Roo

m 4

13R

oom

417

Roo

m 4

21R

oom

429

Roo

m 4

33R

oom

437

Roo

m 4

41R

oom

445

Roo

m 4

53R

oom

457

Roo

m 4

61R

oom

465

Roo

m 4

69

Roo

m 5

04

Roo

m 5

05

Roo

m 5

08

Roo

m 5

09

Roo

m 5

12

Roo

m 5

13

Roo

m 5

16

Roo

m 5

17

Roo

m 5

20

Roo

m 5

21

Roo

m 5

28

Roo

m 5

29

Roo

m 5

32

Roo

m 5

33

Roo

m 5

36

Roo

m 5

37

Roo

m 5

40

Roo

m 5

41

Roo

m 5

44

Roo

m 5

45

Roo

m 5

52

Roo

m 5

53

Roo

m 5

56

Roo

m 5

57

Roo

m 5

60

Roo

m 5

61

Roo

m 5

64

Roo

m 5

65

Roo

m 5

68

Roo

m 5

69

Roo

m 6

04R

oom

608

Roo

m 6

12R

oom

616

Roo

m 6

20R

oom

628

Roo

m 6

32R

oom

636

Roo

m 6

40R

oom

644

Roo

m 6

52R

oom

656

Roo

m 6

60R

oom

668

SEATING AREA

PLAN

TER

SEATING AREA

PLAN

TER

SEATING AREA

PLAN

TER

SEATING AREA

PLAN

TER

SEATING AREA

PLAN

TER

FX FX

FX

FX

FHC

FX

FX

FX

FX

FX

FX

FX FX

FX

FXFHC

FX

FX FX FX FX FX FX FX FX

FHC FXFHCFXFHCFHCFHC

FX

FHB

EXIT EXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXIT

EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT

HALL WB4 ENTRANCEHALL WB2 & WB3 ENTRANCE

HALL WA4 ENTRANCE HALL WB1 ENTRANCE

HALL WA3 ENTRANCEHALL WA2 ENTRANCEHALL WA1 ENTRANCE

30'10'10'10'

18'9'3"9'4"

18'

10'76'

10'

27'10'

17'6"7'8"

19'10' 10'

17'6"8'

10'19'

10'

FIR

E D

OO

RD

O N

OT

BLO

CK

39' 39'39'2"39'2"

16'-6"10'

10'-8"

10' 10'

5'5"

10'

16'-6"10'

10'-8" 16'-6"10'

10'-8"10'

18'-6" 34' 10'-7"10'

46'-4" 46'-5" 10'-7" 30'-8"11'-4"

WA1 WA2 WA3 WA4 WB1 WB2 WB3 WB4

WF WF WF WF WF WF WF WF WF WF WF

WFWF

WF

UPDN

UPUP

DIRECTIONAL

DIRECTIONAL

DIRECTIONAL

DIRECTIONAL

FIR

E D

OO

RD

O N

OT

BLO

CK

BLO

CK

DO

NO

T

#4 #5 #6 #7Seating Area Seating Area Seating Area Seating Area8'

21'

27'

8'21'

8'21'

8'21'

27'TILED FLOOR AREA TILED FLOOR AREA



L2-01A

L2-0

1B

L2-03

L2-04A L2-04B

L2-05

L2-06L2-07

L2-09B L2-09A

L2-10 L2-14

L2-15A L2-15B

L2-12L2-13

L2-17A L2-17B

L2-16A L2-16B L2-16C L2-16D L2-16EL2-18

L2-23

L2-19

L2-20A

L2-20C

L2-20B

L2-24A L2-24B

L2-26A L2-26CL2-26B

L2-21 L2-22 L2-28A L2-28BL2-29 L2-34

L2-25A L2-25B

L2-32L2-33

L2-37A L2-37B

L2-36A L2-36B L2-36C L2-36D L2-36EL2-41

L2-39L2-40

L2-38 L2-42 L2-43

@75.625" @76" @75.75"

NOTMEASURED

(HAD MIS WRAP)

0001

0002

PR

IVA

TE E

XP

O M

EE

TIN

G S

UIT

ES

INDUSTRYEXPERT

SESSIONS

FOOD COURT

AADTHE CONNECTION

(e-Posters andPresentations,AAD Resource

Center,Networking

Center/e-Center)

EXHIBITS

▲

2018SPACE

SELECTIONOFFICE

Circadia by Dr. Pugliese ................................2478Clinical Resolution Lab Inc. ...........................1867CLN Skin Care (TopMD Skin Care) ...............1114CNH Pillow Inc. ...........................................3219Coalition of Skin Diseases .............................2735Cobalt Medical Supply Inc. ............................1115CoLabs International Corp. ...........................3419Collagen P.I.N. ..............................................1688Compulink Business Systems Inc. .................2675Coolibar, Sun Protection You Wear ................1432Corrona LLC .................................................1676Cortex Technology Aps ..................................2622CosMedical Technologies LLC .......................2470Cosmofrance Inc. ..........................................3553CPa Medical Billing .......................................2971CRC Press - Taylor & Francis .........................1563Crown Laboratories Inc. ................................2435CryoProbe ....................................................1054Crystal Clear Digital Marketing .....................3508Cu-Tech ........................................................1213CureMD Healthcare ......................................2074Cutanea Life Sciences Inc. .............................2889Cutera ..........................................................2527Cutis & Cosmetic Dermatology .....................1767Cynosure ......................................................1439Cynova Laboratories ......................................1183

DD-Path Dermatopathology .............................3359Daavlin .........................................................3153DANA ..........................................................3492DefenAge .....................................................1286DEKA Medical ..............................................1469Delasco .........................................................1505Demandforce Inc. .........................................1004Derm101 .......................................................2923Derma Faith LLC ..........................................3575Dermablend .................................................1960DermapenWorld-Equipmed USA ..................2583DermaSweep ................................................2075Dermatologic Cosmetic Laboratories .............1427Dermatologist, The .......................................2822Dermatology Associates ................................3460Dermatology Foundation ..............................3310Dermatology News ........................................1769Dermatology Solutions Group .......................1788Dermatology Times ......................................1527DermLink Inc. ..............................................2581DermOne LLC ..............................................1056DermoScan GmbH .......................................1377Dermpath Diagnostics ..................................1353Dermpath Lab of Central States .....................3327DermResources LLC .....................................2370DermTech ....................................................2276Dermwise .....................................................3541

Designs for Vision Inc...................................2078Dino-Lite Scopes (BigC) ................................1575Dow Development Laboratories .....................3408Dr. Marder Skincare ......................................3583DRE Medical Inc. ..........................................3464

EeClinicalWorks..............................................1877Eclipse Aesthetics LLC ..................................2875Elekta ...........................................................3509Ellipse Inc. ....................................................1023Ellis Instruments ..........................................1626ELON Hair, Nails & Skin ...............................3188Elsevier .........................................................3205EltaMD SkinCare ................................1026, 1319Emirates Dermatology Society .......................1770Emvera Technologies LLC .............................1978EndyMed Medical Ltd. ...................................2981Envy Medical ................................................1219Epionce ........................................................1775Erchonia Corp. ..............................................1953eRelevance Corp. ..........................................1029Espada Dermatology .....................................1778EunSung Global Corp. ..................................3169Euro-Asian Association

of Dermatovenerologists ...........................1021European Academy of Dermatology

and Venereology .......................................0001

Exeltis USA...................................................3531EZDerm LLC ................................................1005

FFeel Good Inc. ....................................3585, 1076Ferndale Healthcare Inc. ...............................2319FibroTx LLC ..................................................1170FIGS ............................................................1281FineMec Co. Ltd. ...........................................1169Focus Medical ...............................................2775Forefront Dermatology ..................................2781Fotofinder Systems Inc. .................................1969Fotona Lasers ................................................1105

GGalderma Laboratories, LP ............................1605Genentech, a Member of the Roche Group ....1305Gensco .........................................................1175GliSODin Skin Nutrients ..............................1474GlitterTots ....................................................1180Glowbiotics MD ............................................2383Gold Bond Ultimate ......................................3475Grand Aespio Inc. .........................................3471Group Health Physicians ...............................3318Guangzhou Huafei Tongda

Technology Co. Ltd....................................1289


Continued from page 11

Many SK patients feel embarrassed about their skin, worry about looking older, and struggle to cover, disguise or deal with the condition.1 SK matters to patients and impacts their daily lives.1

The majority of patients with SK are interested in a treatment option that is unlikely to scar and does not involve cutting, burning or freezing.1

Learn more at booth #3526 and SKMatters.com

MORE THAN 83 MILLION AMERICANS HAVE SK.2

83 OF SK PATIENTSARE INTERESTED IN TREATMENTand willing to pay out-of-pocket1

%

1Data on File. Aclaris Therapeutics SK In-offi ce Observational Study, 406 dermatology patients, 2016. 2 Bickers DR, et al. The burden of skin diseases: 2004. J Am Acad Dermatol 2006; 55:490-500.

© 2017 Aclaris Therapeutics Inc. All Rights Reserved.

HHaircheck .....................................................3423HairMax-Lexington International...................1675Hankins Consulting ......................................1066Hans Biomed USA Inc. .................................1078Hansderma ...................................................3518Hayden Medical Instruments ........................1870Healio Dermatology ......................................1090Heine USA Ltd. ............................................3161Henry Schein ................................................1274Hidrex USA ..................................................3414Hill Dermaceuticals Inc. ...............................1426Hill Laboratories Co. .....................................3427Hill Top Research .........................................1831Hironic Co. Ltd. ............................................1288Horus-Adamo SRL ........................................1177HRA Healthcare Research & Analytics ..........1116Hy-Tape International ...................................1019HydraFacial MD - Edge Systems LLC .............1515HydroPeptide ...............................................2483

IIagnosis Inc./DermatologistOnCall ...............3363Ibero Latin American College of

Dermatology/CILAD .................................1689IFC SA .........................................................1381ILOODA Co. Ltd. ..........................................1187Image Skincare .............................................1275Infinity Massage Chairs.................................3488Innovaderm Research ...................................1165Innovative Optics Laser Eye Protection ..........2326Innovative Skincare .......................................1489Integrated Dermatology Group ...........2767, 3022Interderma, S.L. ............................................3366International Society of Dermatology .............3313

Irmat Pharmacy ............................................3459ISDIN.................................................2389, 2489

JJAMA Network, The ......................................3405Jan Marini Skin Research ..............................2535Janssen Biotech, Inc. .....................................3005JILIN PROVINCE KING LASER

TECHNOLOGY CO. LTD...........................2886Johnson & Johnson Consumer Inc. ...............2805Journal of Clinical and Aesthetic

Dermatology .............................................2565Journey Medical Corp. ...................................3462JP Medical Publisher .....................................1044

KKaiser Permanente ........................................3035Kao USA Inc. ................................................3333Karger Publishers .........................................1205KCD Medical ................................................1966Kernel Medical ..............................................1375

LLa Roche-Posay .............................................1661Laboratoires Filorga ......................................3375LASERING SRL ............................................3321Laseroptek Co. Ltd. .......................................3481Laservision ...................................................1130LC Cell .........................................................3287LEO Pharma Inc. ................................2827, 3211LIFTLAB Skin Regeneration .........................2787Light Age Inc. ...............................................1433LightScalpel ..................................................3504Lilly USA, LLC ....................................3435, 3545Lipotec USA Inc. ...........................................1013LIPSMART ...................................................1074Locks of Love Inc. .........................................1308

Lumenis .......................................................2541Lutronic ........................................................2867

MMartiDerm ...................................................1060Mastocytosis Society Inc., The .......................1291Mayne Pharma .............................................1481Mayo Clinic ..................................................1193McGraw-Hill Education .................................3291MCV Physicians-VCU Health ........................1693md:ceuticals ..................................................3387MedCo Data ..................................................3368Medesthetics Magazine .................................2785Medicol USA ................................................1032Medimetriks Pharmaceuticals .......................1207MEDWEB .....................................................1366Melanoma Foundation of NE/

Brightguard ..............................................3589Mentholatum Co., The ..................................3515Mercedes Medical .........................................3269Merz .............................................................3015Mesoestetic SL ..............................................2680MetaOptima Technology Inc. ........................2684Microsurgery Instruments Inc. ......................2536Midmark Corp. .............................................2727Miraca Life Sciences ......................................2575Miramar Labs Inc. ........................................1035Mission Pharmacal Co. .................................1975MJD Patient Comm/

TopDocs.com ............................................2523Modernizing Medicine Inc. ...........................2665MoleSafe ......................................................1774MolluscumRx. ..............................................1006Mother To Baby Pregnancy Studies

conducted by OTIS....................................1329MTI Inc. .......................................................3343Mylan Inc. ....................................................3563Myriad Genetic Laboratories Inc. ...................1052

NNanbu Plastics Co. Ltd. .................................1282National Biological Corp. ...............................2453Nelly De Vuyst Derme & Co. .........................3261NeoGraft.......................................................3520NeoStrata Co. Inc. .........................................1539Neutrogena ...................................................2505New Beauty Magazine ...................................1331New Medical Technology Inc. ........................1974NEWPONG CO. Ltd. .....................................3581NewSurg .......................................................1008Nextech ........................................................2417NextGen Healthcare ......................................3519NIA24 ..........................................................1290NIAMS .........................................................2327NoIR LaserShields ........................................1327NovaCutis Inc. ..............................................1577Novartis Pharmaceuticals Corp. .. 1627, 1635, 1937Novella Clinical .............................................1367Novoxel Ltd. ..................................................1080Nutrafol ........................................................1012NY LASER OUTLET .....................................1016

OOculo-Plastik Inc. .........................................1118OCuSOFTSkin Care ......................................3260Officite .........................................................1674Omni Bioceutical Innovations .......................3381Omnilux .......................................................3559Ontos Inc. .....................................................1011Otto Trading Inc. ................................1027, 1270Outcome Health ...........................................1075Oxygenetix Institute Inc. ...............................1875

PPalmer’s .......................................................2969

Continued on page 16

Novartis Pharmaceuticals CorporationEast Hanover, New Jersey 07936-1080 Printed in USA © 2017 Novartis 2/17 T-COS-1340535

Novartis acts in accordance with the PhRMA Code on Interactions With Health Care Professionals. The PhRMA Code states that inclusion of a health care professional’s spouse or guest at an educational program is not appropriate. Your support of these ethical guidelines will help to ensure a high quality learning environment for all participating health care professionals. Thank you.

This program is independent and is not part of the of� cial AAD Annual Meeting, as planned by its Scienti� c Assembly Committee. This program does not qualify for continuing medical education (CME) credit.

Cyndi Lauper

Featured Patient:

Jeffrey Weinberg, MD

Presented by:DINNER SYMPOSIUMSunday, March 5, 20176:30 PM – 7:00 PM Registration 7:00 PM – 10:00 PM ProgramOrange Ballroom E-G • Hilton Orlando • Orlando, FLPlease arrive at 6:30 PM to register.Dinner will be provided.

Hear Cyndi Lauper’s Story

This Industry Expert Session is a promotional activity and is not approved for continuing education credit. The content of this session and opinions expressed by presenters are those of the Presenting Company or presenters and do not represent an endorsement by, nor imply that the products have been evaluated or approved by the American Academy of Dermatology.

Expert Rheumatologist Sergio Schwartzman, MD

Expert Dermatologist Paul Yamauchi, MD, PhD

Presented by:INDUSTRY EXPERT SESSIONSaturday, March 4, 201710:45 AM – 11:00 AM Registration11:00 AM – 11:45 AM ProgramIndustry Expert Theater inside Exhibit HallOrange County Convention Center - West • Orlando, FLPlease arrive at 10:45 AM to register.Lunch will be provided.

Hear Expert Insights on What’s Possible With COSENTYX

Join us for these exciting eventsat this year’s AAD Annual Meeting!

CELEBRATING OUR HISTORY AT BOOTH #1635


FullPage.indd 1 2/1/17 11:31 AM

PatientPoint ..................................................1014Payspan Inc. .................................................1084PCA Skin ......................................................1253Peninsula Medical .........................................3191PerfAction Technologies ...............................3089Perigee .........................................................1581Perimed Inc. .................................................2379Perrigo .........................................................3264Person & Covey .............................................1668Pfizer Inc. .....................................................2589Philips Respironics .......................................3533PhotoMedex ..................................................2135PhytoCeuticals Inc. .......................................3163Pierre Fabre USA ..........................................3041Practical Dermatology ...................................3062Precision Medical Devices LLC ......................1287PRIME Journal .............................................1030ProCell Therapies .........................................3570Procter & Gamble .........................................2231Proinnovera GmbH ......................................1091Promius Pharma...........................................1461Promoitalia Group S.P.A. ..............................1386ProPath Dermatopathology ...........................2027PSI/Vanicream Skin Care ..............................2127Psoria-Shield Inc. ..........................................1068

QQuanta USA .................................................3063Quantificare ..................................................2474Quintessence Skin Science ............................3130

RRa Medical Systems Inc. ................................2567Refine USA ...................................................2482Regen Lab .....................................................3407Regeneron/Sanofi Genzyme ..........................3175

RegimenMD LLC ..........................................1266Restoration Robotics .....................................3239Revision Skincare .........................................1241Riverchase Dermatology................................3591Robbins Instruments ....................................1304Rohrer Aesthetics LLC ...................................2791Rose Micro Solutions ......1126, 1930, 2064, 3445

SSamumed LLC ..............................................3537Sanford Health .............................................3267SanovaWorks (including JDD) .......................3320SanSoleil...Sun Care You Can Wear... .............1593Sawgio LLC ...................................................2880Scar Heal ......................................................2174Schweiger Dermatology Group ......................3523SciBase .........................................................1120Sciton ...........................................................1819SCS Direct Inc. .............................................3513Sebamed USA...............................................3286Sebela Pharmaceuticals Inc. ..........................3365Sensus Healthcare ........................................2275Sente ............................................................3567Sesderma ......................................................1313SESHA Skin Therapy ....................................3410Shantel Medical Supply .................................2623SharpLight Technologies Ltd. ........................3314Shenzhen GSD Tech Co. Ltd. ........................1278SILAB...........................................................3486Sinclair Pharma ............................................2989Skin ..............................................................1017Skin & Cancer Associates/

Advanced Dermatology Mgmt ...................2963Skin Cancer Foundation, The ........................3221Skin Disease Education Foundation ..............1771SkinCeuticals ................................................1653SkinGen International Inc. ............................1020SmartPractice ...............................................2823Society of Dermatology Physician Assistants ..3315

Solumbra by Sun Precautions ........................3353Solutionreach................................................3528Sterilis LLC ...................................................3571Stiefel, a GSK company .................................1389STRATA Skin Sciences .................................2035StrataDx .......................................................1961Stratpharma Switzerland ...............................1182Sun Pharma ..................................................3127Sun Products ................................................2741Sun Protection Zone .....................................3031Suneva Medical .............................................1667SurgiTel/General Scientific Corp. ..................2271Swiss-American Mfg. & Product

Development ............................................2834Symbio LLC ..................................................3406Syneron Candela ...........................................2953Syris Scientific ..............................................3404

Ttaberna pro medicum ....................................2227Tender Corp. .................................................1293Teoxane Laboratories ....................................1088Tergus Pharma LLC ......................................3564Theradome Inc. ............................................3557Thermi .........................................................3081ThermoTek Inc. ............................................2175Tiemann-Bernsco..........................................2405Tilley Endurables ..........................................2922Tizo by Fallene Ltd. .......................................1719TKL Research ...............................................1065Topix Pharmaceuticals Inc. ...........................2019Total Clinical Trial Management ....................3590

UUnder Skin ...................................................2722Unilever .......................................................2835United Skin Specialists .................................3487Unity Point Health-Methodist Proctor ...........1589

University of Florida Health Pathology Laboratorie ................................3489

UV Skinz Inc. ...............................................3369UVBIOTEK ..................................................1591

VValeant Pharmaceuticals

North America LLC ...................................2005Venus Concept USA Inc. ...............................1121Viscot Medical LLC .......................................2274VisualDx .......................................................3544Vivacare ........................................................1671Viveve Inc. ....................................................3465Viviscal Professional .....................................1082VivoSight ......................................................1475Vydence Medical ...........................................1031

WWallaroo Hat Co............................................1569West-TeleVox Solutions .................................1619Wiley ............................................................2060Wolters Kluwer .............................................1529WON TECH Co. Ltd. .....................................2883

X-YXoft-a subsidiary of iCAD Inc. .......................3413XTETIC ........................................................2975Young Pharmaceuticals Inc. ..........................1553

ZZELTIQ .......................................................1231Zero Gravity .......................................1087, 3586Zimmer Medizin Systems .............................1361ZO Skin Health Inc. ......................................2069Zocular .........................................................3469

Continued from page 12

PREPARED BY FCB

Job #: 10687590Releasing as: Native file Production: S. Curry x3029

Colors: 4C AD: C. Anderson

Client: Pfizer AE:

Product: Eucrisa Bleed: 11.125”w x 15.25”h Producer: L. Burgess

Client Code: Trim: 10.875"w x 15"h QC: L.Powell

Date: January 19, 2017 5:44 PM Safety: 10.375"w x 14.5"w Digital Artist: tp,BD, tp, BB, tp,BD

Proof: M6FRAdd’l Info:

Fonts: Co Text M1 Spellcheck: M. Benedetto

FR Spellcheck: Luigi Mennella

Path: PrePress:Pfizer:Eucrisa:10687590:_PACKAGED:10687590_AAD_Annual_Mtg_News:10687590_AAD_Annual_Mtg_News_M6FR

4C Eucrisa AAD Annual Meeting News Ad

AAD food court

Entrance to convention hall

at booth #2589

Now Approved!Connect•the•dots to learn more

PP-CRI-USA-0201 © 2017 Pfizer Inc. All rights reserved. Printed in USA/January 2017

S:10.375”S:14.5”

T:10.875”T:15”

B:11.125”B:15.25”

10687590_AAD_Annual_Mtg_News_M6FR.indd 1 1/19/17 5:52 PM


Tips for closing surgical defects to be presentedBy Terrence A. Cronin Jr., MDSession Director

D ermatologists from the Florida Society of Dermatologic Surgeons will make four presentations

during a Saturday session on new and better ways to close surgical defects from skin cancer removal:• “Creating the Ideal

Linear Closure,” Jonathan Kantor, MD

• “Surgical Approaches to Multiple Cutaneous Carcinomas,” Terrence A. Cronin Sr., MD

• “Rotation Flaps: How They Work and Where to Put Them,” Andrew Weinstein, MD, MPH

• “Maximizing Your Dermatologic Surgery Outcomes,” Susan Weinkle, MD

A lot of the innovations in wound closure develop among those dermatologic surgeons deep in the trenches of treating the skin cancer epidemic. Whether it’s new suture material, stitching techniques, or new flaps and grafts, I’m pleased that

these Florida experts are presenting their pearls and advancements to our AAD audience. Certainly, all attendees will improve their surgical knowledge and be able to help their skin cancer

patients more effectively.Material covered by speakers will

include:• New research data that shows

advances in suturing techniques• New methods that were effective and

elegant for treating multiple wounds at the same time

• New surgical methods for closing skin cancer wounds effectively and cosmetically

Nanotechnology may be used to deliver natural immunomodulatory and anti-neoplastic ingredients

A dam Friedman, MD, will present “Nanotechnology and Immunomodulators” during a Sunday session. He

is an associate professor of dermatology, residency program director, and director of translational research at George Washington University School of Medicine and Health Sciences in Washington, D.C.

Q: What is the focus of your presentation?A: I will present new data on how nanomaterials can effectively deliver and use natural ingredients that have the potential to greatly impact both inflammatory and neoplastic diseases of the skin.

Q: What natural agents will you discuss in your presentation?A: 1. Curcumin, which is the polyphenol that gives the Indian spice tumeric its yellow color and numerous medical benefits, from wound healing to cancer.

2. Sanguinerine, which is the active ingredient in blood root made notorious by internet-based, dangerous skin tag removal products, which, when used correctly, has potent anti-melanoma properties. 3. Chitosan, which is a structural carbohydrate derived from the chitin in crustacean exoskeleton that has potent anti-acne, anti-inflammatory, and anti-microbial properties. 4. Cannabinoids, which are the chemical compounds THC and CBD secreted by cannabis flowers that confer an ever-emerging array of therapeutic properties, including pain control, anti-inflammation, and anti-neoplasia. These and many other naturally occurring medicinal ingredients are unified by a common thread; they are inherently unstable and difficult to deliver through and to the intended target — the skin.

Q: How does nanotechnology factor into this?A: Nanotechnology is the science of really really small. How small? One-billionth of a meter. Nano-sized materials can be designed

and tailored to stabilize, target, and deliver these multifaceted agents in ways that have never been accomplished in the past. Through nanotechnology, the translation from plant to person can be realized.

Q: Why is nanotechnology so important in using these agents?A: Our ability to capitalize on the unique

properties of many naturally derived ingredients is hindered by their poor bioavailability, stability, and cosmesis. Nanotechnology can be tailored to overcome all of these limitations and enable us to translate the wealth of bench research on ingredients such as curcumin, sanguinerine, and even cannabinoids to the bedside.

Filler complications: BlindnessBy Katie Beleznay, MDVancouver, BC, Canada

N ew research on complications from filler treatments, the most serious of which is related

to injecting into the blood vessels with the possible resulting complication of blindness, will be presented in an education session Sunday.

In the world literature to date, there are at least 98 cases of blindness from fillers. Only one of those cases had complete vision recovery, so this complication is most commonly irreversible. To highlight the significance of this issue, the Food and Drug Administration recently issued a safety communication about the risk of intravascular injection with fillers.

One of the most important preventive steps is knowing the location of blood

vessels and the proper depth of injection for the filler, so the session will review the relevant facial anatomy and shared treatment strategies, as well as a protocol that physicians should implement if they run into one of these unfortunate complications.

Other presentations:• Legal Issues of Filler Complications • Infection, Sensitivity, Granulomas• Vascular Compromise• Peri-orbital• Global Filler Complications• Cheeks/Mid-Face• Lips/Chin/Oral Commissure• Dorsal Hands• Temple/Forehead• Database of Filler Complications

Treating Tumors and Inflammatory Skin Diseases with Immunomodulators and Biologics (F120)

3:30-5:30 p.m. Sunday

Room W307D

Adam Friedman, MD

Breaking News

Avoiding and Managing Filler Complications (C023)

1-4 p.m. Sunday

Room W415A

Breaking News

Wound Closure Design: Basic to Advanced (F078)

1-3 p.m. Saturday

Room W307D

ROZATROL™

Treatment For Red, Sensitized Skin

zoskinhealth.com

Decrease in severity of rosacea, flushing and redness symptoms at six weeks.

BASELINE 6 WEEKS

BASELINE 6 WEEKS

Nearly 80% of rosacea patients reported having to use more than one medication to manage the condition.*

Rozatrol™ features a multiplex of ingredients to relieve the multiple symptoms known to be associated with rosacea. All in One Tube.

THE BEST SOLUTION ISONE SOLUTION

PATENT PENDINGCLINICALLY PROVEN

VISIT US AT BOOTH #2069*Independent third party study of 22 subjects to assess the efficacy potential of Rozatrol™ in minimizing the signs and symptoms of Rosacea. Subjects were evaluated at 2, 4, and 6 weeks with the following protocol AM and PM: Oilacleanse™, Rozatrol™ and Oclipse-C™ SPF 50 in the AM. *Source: National Rosacea Society Survey


Learn more at Booth 2053

64V-1896028_2017_AAD_DailyNews_Plum.indd 1 1/18/17 1:46 PM



Learn more at Booth 2053

64V-1896028_2017_AAD_DailyNews_Plum.indd 1 1/18/17 1:46 PM

Breaking News

Preliminary data from VIP trialsStudies explore relationship between skin, coronary disease

T he negative effect of skin disease on vascular disease is the focus of several recent studies.

Data from two of those studies, the Vascular Inflammation in Psoriasis (VIP) trial and its related extension trial, VIP-E, as well as an observational cohort study, the Psoriasis Atherosclerosis Cardiometabolic Initiative (PACI), will be discussed Saturday during “Biologics: Perils and Promise.”

Two presentations in the session will look at the initial information from the VIP trial and PACI study, each using simultaneous imaging modalities, positron emission tomography (PET) and computed tomography (CT) to better understand the relationship between skin disease and vascular disease in patients with psoriasis, said Nehal N. Mehta, MD, MSCE. He will present “Imaging Vascular Diseases in Psoriasis” and Joel M. Gelfand, MD, MSCE, will present “Impact of Psoriasis Biologics on Cardiovascular Risk: Relevance for Clinical Practice.”

“We are going to show preliminary data about how treatments of skin disease may impact aortic vascular inflammation detected by PET/CT.

Dr. Gelfand will introduce preliminary results, and I will follow up with longitudinal data from our NIH

cohort,” said Dr. Mehta, chief of the Section of Inflammation and Cardiometabolic Disease at the National Institutes of Health.

VIP is a randomized, controlled trial with three arms that used FDG PET/CT to study the effects of

adalimumab versus phototherapy versus placebo on the primary outcome of aortic vascular inflammation at 12 weeks. VIP-E examined the results in those patients at 52 weeks. VIP and VIP-E are the first in a series of trials about the effects of skin disease on coronary arteries. Other ongoing trials are looking at the effects of ustekinumab and secukinumab, Dr. Mehta said.

Other presentations during the session:• “Unique Clinical Scenarios in

Psoriasis”• “Update on New and Emerging

Psoriasis Medications”• “Biosimilars: Clinical Study

Design, Extrapolation, and Interchangeability”

• “The Risk of Infection and Malignancy With Biologic Therapy”

Biologics: Perils and Promise (S030)

1-4 p.m. Saturday

Room W415A

Tips to keep your patients relaxed

I n the course of everyday work, people become creative, finding ways to save time and get better results. Friday, four dermatologists

regaled a large, interested audience as they reviewed favorite tips — from working positions to folding drapes to helping patients relax — during “Simple Tricks and Practical Tips to Optimize the Surgical Experience for You and Your Patients.”

Charlene Lam, MD, MPH, kicked off the discussion on a technical note by showing images of closure techniques

she relies on in difficult situations. This included the purse string, which she said she likes to use on skin with laxity, concavities, ears, the scalp, and full-thickness graft donor sites.

Dr. Lam also advised on the importance of correct positioning. A surgeon who is in an uncomfortable position may hurry through a procedure, which takes a toll on the body and could lead to medical complications in the patient. It is best to stand straight and look down at the patient with the head

See TIPS page 25

Amping up social media

Charlene Lam, MD, MPH, discusses the usefulness of wound closure procedures Friday during “Simple Tricks and Practical Tips to Optimize the Surgical Experience for You and Your Patients.”

Annual Meeting attendees posed for a fun selfie Friday at the AAD Resource Center in The Connection, in Hall B4. Stop by the Selfie Station to take part in the fun. The first 200 attendees to participate will have an opportunity to take home a free selfie stick.

Patient Encounter sessions dealing with “Medication Management,” “The Difficult Patient,” “Breaking Bad

News,” and “Total Body Skin Exam” will take place throughout the Annual Meeting. The sessions give attendees an opportunity to focus on a specific topic and learn new skills or hone skills they already use in practice.

Visit www.aad.org/meetings/annual-meeting for availability.

Patient Encounters


AAD’s Skin Condition of the Day

The winner will receive a $25 Starbucks gift

card from AAD.

Text* “AAD Saturday” and your answer to 80802.

One winner will be selected from all correct texts received by 2 p.m. Saturday.

Identify this skin

condition and win!

The correct answer to yesterday’s Skin Condition of the Day is: Seborrheic Keratosis. For more information, go to SKMatters.com

Thank you to all of the participants. Congratulations to Katie Keel, Midstate Skin Institute in Ocala, Florida, recipient of the $25 Starbucks gift card.

Support for this program is being provided by Aclaris Therapeutics, Inc.

Today’s answer is available at

Aclaris Therapeutics, Inc. (Booth 3526) and will be published in tomorrow’s

edition of Dermatology World Meeting News

Images provided by Visual Dx

* Standard message rates apply

H alf of women in their 20s deal with the physical and emotional scarring of acne, and many have turned to

using spironolactone as a treatment, but it is associated with side effects. New evidence has been published about how to best deal with those side effects.

Spironolactone is an antiandrogen that is effective in controlling hormonal cystic/scarring breakouts in patients with acne within three months. However, physicians are concerned about the possibility of elevated blood potassium levels in patients using greater doses of spironolactone, said Shari Marchbein, MD. Other side effects include irregular menses and breast tenderness.

Dr. Marchbein, assistant professor of clinical dermatology at New York University Langone School of

Medicine, will discuss the use of spironolactone during a Saturday session, “Practical Guidelines for Using Spironolactone in Acne Patients.”

“There is a paucity of literature regarding the appropriate use, safety, and monitoring guidelines for spironolactone,” she said. “A 2015 article in JAMA Dermatology has given strong evidence that periodic blood monitoring to check for elevated serum potassium

levels is not warranted. “Most patients do not experience any

abnormalities during spironolactone therapy. This is helpful in that it saves the patient from unnecessary blood draws, as well as saving health care dollars on unneeded tests.”

Other presentations during the session will address using spironolactone for treatments other than acne, such as high blood pressure and edema.

Breaking News

Practical Guidelines for Using Spironolactone in Acne Patients (F075)

1-3 p.m. Saturday

Room W208A

Blood monitoring not needed in acne treatment

Allergic dermatitis in children

C onventional wisdom long has suggested that allergic dermatitis is uncommon in children. The reality is,

children suffer from allergic dermatitis as frequently as adults. The most common culprits are chemicals in personal care products.

“There are over 4,000 chemicals that we are exposed to on a daily basis, and only 35 of them are acknowledged by the Food and Drug Administration as allergens,” said Sharon E. Jacobs, MD, professor of dermatology at Loma Linda University and founder/CEO of The Dermatitis Academy, an online information resource for patients and parents. “Children with persistent allergic contact dermatitis need patch testing just as much as adults do.”

Dr. Jacobs explored the current realities of allergic contact dermatitis in children Friday during “The Truth About Pediatric Contact Dermatitis” (U009). Data from the Pediatric Contact Dermatitis Registry found that 48 percent of children tested were contact sensitized with 65 percent clinical relevance—rates nearly identical to published adult data.

More recent data from a survey of 252 pediatric providers found that children with allergic dermatitis are 17 times more likely to have a positive patch test than children without allergic dermatitis and 110 times more likely to have generalized involvement.

“We need to test more children,” Dr. Jacobs said. “We are missing a lot of patients who need serious help. Patients with allergic dermatitis have a history of dermatitis for 3.5 years compared to 1.8 years for other patients.”

Pediatric patch test studies identified the top allergens as: neomycin, balsam of Peru, fragrance mixes, lanolin, cocamidopropylbetaine, formaldehyde, corticosteroids, methylchlorisothiazolinone (MCI)/methylisothiazolinone (MI), propylene glycol, and benzalkonium chloride.

Other common pediatric allergens include detergents, parthenolide/compositae, nickel, cobalt, colophene, chromates, glucoside, and p-phenylenediamine, or PPD.

Those agents are commonly used in fragrances, cleaning products, cell phones, metal furniture, jewelry, foods, henna, medications, personal care, and other products commonly found in homes, schools, daycare centers, and parents’ skin.

A third of toys have been found to release nickel and cobalt. Toilet seats in schools and other public areas may be cleaned with harsh detergents and incompletely rinsed, causing allergic reactions. Black henna tattoos are a common source of allergens and should never be applied to children. Glucoside is found in many personal care products, including infant sunscreens.

“One of the most common sources of allergens is cosmetics, fragrances, hair dyes, and personal products used by parents,” Dr. Jacobs said. “Sometimes finding the source takes some sleuthing. It can be as obvious as a new rubber mat in a daycare center or as elusive as glue used in a bra or shoes.”

One of the most effective steps to treat allergic dermatitis is to remove the allergen. Pre-emptive avoidance strategy (PEAS) can effectively cure about one-third of children with persistent allergic dermatitis.

Avoidance may mean removing the product from the environment, such as offensive fragrance. It may also mean protecting items that cannot be avoided, such as putting duct tape over the rubber on soccer shin guards that are emitting allergens.

Pick up the Experience guideThe Experience AAD in Orlando onsite meeting guide is available in racks throughout the convention center. It has all of the vital information about the meeting:• How to navigate AAD 2017• Daily highlights• AAD honors and awards• Education information• Exhibit hall floor plan and exhibitors• Convention center maps• City information

Sharon E. Jacobs, MD: “There are over 4,000 chemicals that we are exposed to on a daily basis, and only 35 of them are acknowledged by the Food and Drug Administration as allergens.”

Current contributors at time of publication.

THANK YOU!

In Recognition of Our

2017 AAD ANNUAL MEETING SUPPORTERSThe American Academy of Dermatology gratefully acknowledges the following Corporate Partners

for providing support of the Academy’s 2017 AAD Annual Meeting.

Through their generosity, we are able to provide the following:

2017 AAD Annual MeetingOrlando, FloridaMarch 3-7, 2017ORANGE COUNTY CONVENTION CENTER

Annual Meeting News Post Edition Level A

Annual Meeting News Preview Edition Level A

Hotel Key Cards

Mobile App

Pocket Guide

™

Advance Registration Mailer

Sharing Mentoring Experiences Breakfast

Partial Support:

Resident Access to Education Program at Annual Meeting

Attendance Verification Monitors

E-Posters Exhibit Area

Leadership and Mentoring Reception

Press Office and Media Appreciation Luncheon

Residents’ Lunch (Thursday)

International Member ReceptionNetworking Center

WiFi

Residents’ Reception (Friday)

Young Physician and New Member Reception

Meeting Concierge Program Vests

Residents’ Reception (Thursday)Stars of the Academy Awards Reception

Partial Support:

World Congress Scholarships

Annual Meeting News Preview Edition Level B

Partial Support:

Resident Access to Education Program at Annual Meeting

Untitled-1 1 2/2/2017 3:25:16 PM

EXPERIENCE • EXPLORE • INTERACTat the

AAD Resource Center in Hall B4

✓ ✓

✓✓

✓✓

• Come take your #AAD17 selfie! The first 200 attendees to post get a FREE selfie stick.

• Discover AAD’s Practice Management Center which features the latest resources designed to help you navigate the ever-changing practice environment.

• FREE professional headshots. HEADSHOT SCHEDULE:

Friday, March 3 10 a.m. – 5 p.m. Saturday, March 4 10 a.m. – 5 p.m. Sunday, March 5 12 p.m. – 5 p.m. Monday, March 6 10 a.m. – 5 p.m.

• Don’t forget our expert staff and Affinity Partners will be on-hand to assist you.

• 10% off select AAD products.

• Receive $50 off your 2017 MIPS reporting plus a FREE gift with DataDerm™ enrollment.

• Pre-order and save $50 on the 2017 Annual Meeting On-Demand Recordings.

• 20% off one AAD product, see coupon below.

SHOP & SAVEWHAT’S NEW

SAVE AT THE AAD RESOURCE CENTER

20% OFFONE AAD PRODUCT*

* Offer only valid at the AAD Resource Center 3/3/2017 – 3/6/2017. Present this coupon at time of purchase. Coupon may only be used once and cannot be used on already discounted or previously purchased items. Discount excludes taxes, shipping and handling, meeting registration, membership dues, DermCare Team enrollment fees, JAAD subscription and third-party products. AMRC17

Present this coupon and get

Friday, March 3 – Monday, March 68 a.m. – 5 p.m. daily


OFTHE NEXT GENERATION

HEALING OINTMENTOINTMENTOINTMENTOINTMENTOINTMENTOINTMENTOINTMENTOINTMENT

CeraVe is a registered trademark of Valeant Pharmaceuticals International, Inc. or its affiliates. All other product/brand names and/or logos are trademarks of the respective owners.

©2017 Valeant Pharmaceuticals North America LLC. CVE.0232.USA.16

CeraVe Healing Ointment

Aquaphor Healing Ointment

Petrolatum base 46.5% 41.0%

Ceramides 1, 3, & 6-II

Contains dimethicone

Accepted by the National Eczema Association

Lanolin free

Fragrance free

Dye free

CeraVe is widely available at these and other retailers:

Its unique formulation is hypoallergenic, non-comedogenic, and protects and soothes the skin.

NON-GREASY FEEL

EXPERIENCE • EXPLORE • INTERACTat the

AAD Resource Center in Hall B4

✓ ✓

✓✓

✓✓

• Come take your #AAD17 selfie! The first 200 attendees to post get a FREE selfie stick.

• Discover AAD’s Practice Management Center which features the latest resources designed to help you navigate the ever-changing practice environment.

• FREE professional headshots. HEADSHOT SCHEDULE:

Friday, March 3 10 a.m. – 5 p.m. Saturday, March 4 10 a.m. – 5 p.m. Sunday, March 5 12 p.m. – 5 p.m. Monday, March 6 10 a.m. – 5 p.m.

• Don’t forget our expert staff and Affinity Partners will be on-hand to assist you.

• 10% off select AAD products.

• Receive $50 off your 2017 MIPS reporting plus a FREE gift with DataDerm™ enrollment.

• Pre-order and save $50 on the 2017 Annual Meeting On-Demand Recordings.

• 20% off one AAD product, see coupon below.

SHOP & SAVEWHAT’S NEW

SAVE AT THE AAD RESOURCE CENTER

20% OFFONE AAD PRODUCT*

* Offer only valid at the AAD Resource Center 3/3/2017 – 3/6/2017. Present this coupon at time of purchase. Coupon may only be used once and cannot be used on already discounted or previously purchased items. Discount excludes taxes, shipping and handling, meeting registration, membership dues, DermCare Team enrollment fees, JAAD subscription and third-party products. AMRC17

Present this coupon and get

Friday, March 3 – Monday, March 68 a.m. – 5 p.m. daily

and neck at an angle between 15 and 40 degrees.

A survey by the American College of Mohs Surgery showed that 90 percent of medical respondents reported some form of musculoskeletal symptoms or injuries, Dr. Lam said. The most common problem areas were the neck (65 percent), lower back (63 percent), shoulders (61 percent), and upper back (53 percent).

Allison Vidimos, MD, RPh, chairman of the department of dermatology at Cleveland Clinic, provided tips ranging from local anesthesia to protecting against eye injuries when using lasers.

For local anesthesia, Dr. Vidimos prefers to improve the patient experience by using lidocaine to begin numbing slowly before using bupivacaine. She then recommends using acetaminophen postoperatively to reduce pain.

Lasers are a danger to the eyes of both patients and health care professionals, so wearing goggles is vital, she said. It is also important to wear different goggles for different types of lasers. Dr. Vidimos recommended marking them clearly, even using color-coded dots on goggles to match dots on the equipment.

Finally, Dr. Vidimos warned the audience about Aschner reflex, in which a patient’s pulse rate can decrease when traction is applied to the ocular muscles or when the eyeball is compressed. She said she became aware of this reflex when a patient coded during a minor procedure she was observing.

Following Dr. Vidimos to the dais was Elizabeth M. Billingsley, MD, who talked about the importance of using drapes. She advocates for the liberal use of drapes to keep sutures and equipment sterile by keeping them from touching tables and chairs during a procedure.

Dr. Billingsley said she asks patients if they are claustrophobic before beginning a procedure because some patients can become anxious when covered by drapes.

“Make sure the patient can breathe, and if you cover the eyes, don’t push on the eyeballs,” said Dr. Billingsley, a professor of dermatology at Penn State Hershey Medical Center.

Marc D. Brown, MD, professor of dermatology and oncology at the University of Rochester, described processes his office uses to keep surgical patients relaxed.

“Stress impairs wound healing by as much as 40 percent,” he said. He urged keeping patients as stress-free as possible, including answering questions from anxious patients following the procedure.

TIPS, continued from page 21 SUNSCREEN, continued from page 1

• Several agents used in sunscreens outside the U.S. could potentially improve sunscreen effectiveness. The Food and Drug Administration has indicated that it needs more data on these ingredients before they can be approved for use, but Dr. Rigel hopes this will be re-evaluated

• Allergies to sunscreen occur in less than 1 percent of the population. Most issues attributed to allergies are actually a reaction to fragrance or using a heavy

sunscreen that may cause acne.• The FDA recommends more studies

on the impact of zinc nanoparticles in sunscreen.

• Sunscreens with antioxidants often may have added sub-therapeutic levels so that they may have little impact on UV protection.

• When using insect repellants and sunscreen, apply the repellant first so absorption into the skin can be minimized.

• Getting a base tan does not help reduce the risks of sun exposure.

• Sunscreen may break down in excessive temperatures, such as in cars parked in the sun in the summer heat, where the temperature can exceed 150 degrees. It remains stable in 100-degree weather on the beach.

The best sunscreen? — “The one people will actually apply and use on a regular basis,” Dr. Rigel said.

To learn more about sunscreen ingredients that have not yet been approved by the FDA, visit www.aad.org/dw/monthly/2016/may/ a-recipe-for-public-health.


Product Spotlight

Get social with the AAD on Facebook and Twitter

A re you following @AADmember on Twitter? If not, we encourage you to join the 7,500+ other followers who get exclusive

updates about the Annual Meeting and share their photos with the AAD for all members to enjoy. See the best selfies from the Selfie Station in the AAD Resource Center by following the @AADmember feed today!

Be sure to also like the new Facebook page designed specifically for AAD Members (@AADmember), which will also be updating followers with news and

information about the Annual Meeting, including posts about new and popular sessions, special events, tourist information, and, of course, shared photos of members and attendees enjoying the meeting.

To share your photos with the AAD, use the official meeting hashtag #AAD17 in all your posts and tweets to engage in conversations and activities throughout the meeting.• Facebook: www.facebook.com/

AADmember • Twitter: www.twitter.com/AADmember

Promotional Offer Booth 2274

www.viscot.com800.221.0658

BOTOX® is a registered trademark of Allergan Inc.

Marking Consultations

Botox®

Injectable Fillers

E•Z Removable Ink™ Skin Marker

Promotional Offer:Booth 2274

Promotional Offer:Booth 2274

So�zone® Syringe TraySingle hand capping of needles

www.viscot.com800.221.0658

Naturally, you want a cold sore to go away fast. Naturally, it can. The secret? Sarracenia. A plant-based SuperBotanical™ that’s been proven to work wonders. Aubio’s exclusive formula works fast to get you back to your beautiful, smiling self. How fast? In a recent study, 100% of Aubio cold sore gel users said they’d use it again.

That fast.

aubío.com

Dermatologist developed. Cools and soothes. Ultra-effective botanicals. As nature intended.

gel users said they’d use it again.

That fast.

Goodbye, cold sore. Hello, beautiful.

Nature’s golden drop.™

AUBI 20909-AdCampaign-2.38x3.18 .indd 1 2/10/2017 1:58:20 PM

Make payment easier at every age and through every stage.

AAD Annual Meeting, Booth #1127 800-300-3046 • carecredit.com

AADTS0317CA

4279 AAD 2.375x3.125 V3.indd 1 2/10/17 3:03 PM

For the latest information on program titles, times, locations, and registration go to

aad.org/incprograms.

Don’t miss out on attending Industry Non-CME (INC) Programs being held in the evening from March 2 – March 5, 2017, in Orlando, FL. At the sponsoring company’s discretion, these programs may be promotional or educational in nature.

Programs are held conveniently at the Hyatt Regency Orlando and/or Hilton Orlando, and cover a range of topics.

These informational programs do not qualify for CME credit, and all content is under the control of the sponsoring company. These events are independent and are not part of the official AAD Annual Meeting as planned by the Scientific Assembly Committee. Pre-registration may be recommended by the sponsoring companies.

Attend an Industry Non-CME (INC) Program

Untitled-1 2 2/2/2017 3:25:17 PM

Meet the AAD Board of Directors

AAD President-Elect Henry Lim, MD, (left) talks with an Annual Meeting attendee Friday in The Connection, in Hall B4. Members of the AAD Board of Directors will be back at The Connection from noon to 1 p.m. today to meet with members. Light refreshments will be served.

This Industry Expert Session is a promotional activity and is not approved for continuing education credit. The content of this session and opinions expressed by presented are those of the Presenting Company or presenters and do not represent an endorsement by, nor imply that the products have been evaluated or approved by the American Academy of Dermatology.

Sponsored by Celgene

Shane Chapman, MDDartmouth Hitchcock DermatologyLebanon, New Hampshire

Moving Beyond Topicals: Perspectives on Systemic Treatment for Psoriasis

I N D U S T R Y E X P E R T S E S S I O N

Friday, March 3, 2017 / 11:00 AM –11:45 AM / Exhibit FloorOrange County Convention Center / Orlando, Florida

This Industry Expert Session is a promotional activity and is not approved for continuing education credit. The content of this session and opinions expressed by presenters are those of the Presenting Company or presenters and do not represent an endorsement by, nor imply that the products have been evaluated or approved by the American Academy of Dermatology.

Pursuant to the PhRMA Code on Interactions with Healthcare Professionals, attendance at this promotional program is restricted to healthcare professionals. Accordingly, spouses and other guests who are not healthcare professionals may not attend this event. Celgene will report transfers of value made to US healthcare professionals to the extent required by federal and state laws, as applicable. To learn about how Celgene Corporation complies with the Physician Payments Sunshine Act visit http://www.celgene.com/about/compliance/sunshine-act/.

© Celgene Corporation 12/16 USII-CELG160070To register, scan the QR code to your mobile device, or visit

http://www.celgenepsoriasisprogram.com

You’re invited to join the discussion!

PROGRAM FACULTY

Questions about sunscreen persist · sunscreen that may cause acne. • The FDA recommends more...

Documents

Transcript of Questions about sunscreen persist · sunscreen that may cause acne. • The FDA recommends more...